TIGIT graveyard expands as GSK drops late-stage asset with iTeos

At last year's ESMO conference, there was hope that the TIGIT field still had a leg to stand on as GSK and its partner iTeos propped up their Phase 2 lung cancer ...

May 13, 2025 - 14:44
 0
TIGIT graveyard expands as GSK drops late-stage asset with iTeos
At last year's ESMO conference, there was hope that the TIGIT field still had a leg to stand on as GSK and its partner iTeos propped up their Phase 2 lung cancer ...